Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for IV vasopressor liberation in septic shock
NCT03706053Phase 3Terminated
- Sponsor
- University of Virginia
- Start
- Nov 2018
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midodrine in septic shock, sponsored by University of Virginia. Started Nov 2018; status: terminated.
02
Drugs
midodrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03706053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03706053.